SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011037
Filing Date
2021-05-11
Accepted
2021-05-11 16:45:32
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 630673
2 ex31-1.htm EX-31.1 17762
3 ex31-2.htm EX-31.2 17268
4 ex32-1.htm EX-32.1 7283
  Complete submission text file 0001493152-21-011037.txt   3186044

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pulm-20210331.xml EX-101.INS 466786
6 XBRL SCHEMA FILE pulm-20210331.xsd EX-101.SCH 40560
7 XBRL CALCULATION FILE pulm-20210331_cal.xml EX-101.CAL 50763
8 XBRL DEFINITION FILE pulm-20210331_def.xml EX-101.DEF 139246
9 XBRL LABEL FILE pulm-20210331_lab.xml EX-101.LAB 282079
10 XBRL PRESENTATION FILE pulm-20210331_pre.xml EX-101.PRE 213139
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 21912006
SIC: 2834 Pharmaceutical Preparations